drugset / Trial / NCT06067841
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
NaSequentialOpen-labelTreatment
Summary
The purpose of this study is to assess the safety, tolerability, and preliminary efficacy of BMS-986460 in men with Metastatic Castration-resistant Prostate Cancer.
Timeline
- Start
- 2023-10-18
- Primary completion
- 2029-08-24
- Completion
- 2031-07-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986460 | Unknown | — | — |